May 17, 2023
Idag släppte Neola Medical sin kvartalsrapport för det första kvartalet 2023. Hör CEO Hanna Sjöström kommentera Q1-rapporten och däribland starten för det marknadsförberedande arbetet och det nya samverkansprojektet som möjliggjorts tack vare ett anslag från Vinnova,...
May 17, 2023
This is a translation of the Swedish press release published 2023-05-17, 08.00 CET Neola Medical AB (publ) today publishes the Q1 report of 2023 (in Swedish). The report is available at the company’s website and is attached to the press release. Attendance at...
May 16, 2023
This is a translation of the Swedish press release published 2023-05-16 Neola Medical AB (publ) announces today that the company has been granted a new patent in the U.S. for an invention. This invention can enable measurement on more patient groups than preterm born...
May 15, 2023
This is a translation of the Swedish press release published 2023-05-15 Neola Medical AB (publ) will participate at ABG Sundal Collier’s Life Science Summit Seminar on May 31. CEO Hanna Sjöström will present the company at 13.00 and the presentation will be followed...
May 10, 2023
During the first quarter of 2023, Neola Medical has initiated the market preparation work before launch of Neola®. As the American market is an important future market, we attend several conferences in the U.S. and create connections with American neonatologists....
May 3, 2023
Shareholders in Neola Medical AB, org.nr 559069–9012 (”the Company”), are hereby given notice of the annual general meeting the 17th of May 2023 at 13.00 in the Company’s office at Ideon Gateway floor 9, Scheelevägen 27, 223 63 Lund. Registration etc. Shareholders who...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPersonal Data Policy
